High Content Ephedra Supplements Subject To Proposed DEA Controls
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplements containing ephedrine and pseudoephedrine "mixtures" with more than 2% concentrations of either or both of the ingredients would be subject to Controlled Substances Act reporting and recordkeeping requirements under a proposed rule published by the Drug Enforcement Administration in the Sept. 16 Federal Register.
You may also be interested in...
Supplements With More Than 5% Ephedrine Subject To DEA Controls
Dietary supplement manufacturers whose products contain chemical mixtures of ephedrine and/or pseudoephedrine in concentrations greater than 5% have until June 30 to submit an application for registration with the Drug Enforcement Administration
Supplements With More Than 5% Ephedrine Subject To DEA Controls
Dietary supplement manufacturers whose products contain chemical mixtures of ephedrine and/or pseudoephedrine in concentrations greater than 5% have until June 30 to submit an application for registration with the Drug Enforcement Administration
Supplements With More Than 5% Ephedrine Subject To DEA Controls
Dietary supplement manufacturers whose products contain chemical mixtures of ephedrine and/or pseudoephedrine in concentrations greater than 5% have until June 30 to submit an application for registration with the Drug Enforcement Administration
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: